Founded in 2015, Confo Therapeutics stabilizes GPCR conformations to unlock previously untargetable receptors. Combining this technology with pharmacologic and biologic insights, it develops a multi-indication drug pipeline aimed at transforming treatments for severe diseases, backed by expert leadership, international investors, and Belgium’s strong scientific ecosystem.
Confo Therapeutics
Confo Therapeutics leverages the dynamic structures of GPCRs to transform drug discovery, developing innovative therapies by targeting complex protein conformations for more precise and effective treatments.
About Confo Therapeutics
Recently Added Startups
Ignize
Ignize leverages over 20 years of pricing expertise in manufacturing with a unique smart pricing algorithm, helping businesses optimize pricing strategies, increase profitability, and make data-driven decisions efficiently.
Sortlist
Sortlist connects companies with expert teams in IT, creative, and marketing, helping 120,000 businesses annually find the right talent-driven partners to build successful growth stories worldwide.
Confo Therapeutics
Confo Therapeutics leverages the dynamic structures of GPCRs to transform drug discovery, developing innovative therapies by targeting complex protein conformations for more precise and effective treatments.
Related Post
Confo Therapeutics funding news – Belgium-based Confo Therapeutics Secures €60Million in Series B Round Funding
Top 10 Funding Wrap of the Week – July 22 – July 26 2024
[Funding alert] Tallinn-based Inspectle Food’s Secures €400,000 in Funding
Belgium
Confo Therapeutics
Confo Therapeutics leverages the dynamic structures of GPCRs to transform drug discovery, developing innovative therapies by targeting complex protein conformations for more precise and effective treatments.
OncoDNA
OncoDNA is a precision medicine company specializing in genomic and molecular analysis for cancer care. It provides oncologists with actionable insights to guide personalized treatment, improve patient outcomes, and advance research in oncology worldwide.
Biotech
Confo Therapeutics
Confo Therapeutics leverages the dynamic structures of GPCRs to transform drug discovery, developing innovative therapies by targeting complex protein conformations for more precise and effective treatments.
OncoDNA
OncoDNA is a precision medicine company specializing in genomic and molecular analysis for cancer care. It provides oncologists with actionable insights to guide personalized treatment, improve patient outcomes, and advance research in oncology worldwide.
Brussels
Confo Therapeutics
Confo Therapeutics leverages the dynamic structures of GPCRs to transform drug discovery, developing innovative therapies by targeting complex protein conformations for more precise and effective treatments.
Cyclecure
Cyclecure is the go-to source for sustainable and circular micromobility solutions.
Contact us: contact@startuprise.co.uk